XML 25 R5.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Consolidated Statements of Shareholder's Equity - USD ($)
$ in Thousands
Total
Common Stock [Member]
Class A common shares [Member]
Additional Paid-in Capital [Member]
Accumulated other comprehensive loss [Member]
Accumulated deficit [Member]
Beginning Balance (in shares) at Mar. 31, 2022   7,381,425      
Beginning Balance at Mar. 31, 2022 $ 108,270 $ 257,990 $ 12,154 $ (6,037) $ (155,837)
Net Income (Loss) (42,429)       (42,429)
Cumulative translation adjustment (1)     (1)  
Stock-based compensation 1,811   1,811    
Net proceeds from shares issued under the at-the-market (ATM) program (Shares)   54,108      
Net proceeds from shares issued under the at-the-market (ATM) program 304 $ 304      
Ending Balance (in shares) at Mar. 31, 2023   7,435,533      
Ending Balance at Mar. 31, 2023 67,955 $ 258,294 13,965 (6,038) (198,266)
Net Income (Loss) (12,853)       (12,853)
Stock-based compensation 913   913    
Issuance of common shares upon the exercise of stock options, Value $ 21   21    
Issuance of common shares upon the exercise of stock options, Share 12,500 12,500      
Issuance of common shares and pre-funded warrants through private placement, net of offering costs   1,951,371      
Issuance of common shares and pre-funded warrants through private placement, net of offering costs (Value) $ 5,707 $ 2,744 2,963    
Ending Balance (in shares) at Mar. 31, 2024   9,399,404      
Ending Balance at Mar. 31, 2024 $ 61,743 $ 261,038 $ 17,862 $ (6,038) $ (211,119)